FDA Defers Final Action On Milnacipran New Drug Application
Forest Laboratories, Inc. (NYSE: FRX) and Cypress Bioscience, Inc. (Nasdaq: CYPB) (the “Companies”) announced that the U.S.
More: continued here
Filed under: Pain / Anesthetics on October 27th, 2008